The U.S. Food and Drug Administration's drug evaluation chief, Richard Pazdur, is set to retire just weeks after taking the new role, a spokesperson for the health regulator said on Tuesday.
The nation's top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job, according to two people familiar with his decision.
